Under Turkish law, only entities registered in Türkiye are eligible to obtain a marketing authorization (“MA”) for medicinal products for human use. This requirement compels global pharmaceutical companies intending to engage in business in Türkiye to establish local presence either through forming a subsidiary or teaming up with a local partner such as a distributor. In case of a partnership (e.g., established through a distributorship relationship), transfer of MA will be one of the main topics to be discussed if and when such partnership comes to an end. This article provides an overview of the regulatory framework governing the transfer of MAs in Türkiye, with a particular focus on transfers where there may potentially be a disagreement between the transferor and the transferee.
According to the Regulation on the Licensing of Medicinal Products for Human Use (“Regulation”) and the Guidelines on Conditions Requiring Re-authorisation for Licensed Medicinal Products for Human Use, in order to transfer an MA, certain documents must be submitted to the Turkish Medicine and Medical Device Agency (“TMMDA”), and the relevant procedures must be completed. Transfer process has two main aspects: (i) submission of the transfer application to the TMMDA and (ii) cooperation of the transferor.
In the application for the transfer, the transferee must submit to the TMMDA: (i) a court decision stating that the transfer of MA has been fulfilled, (ii) an execution office decision stating that the license has been sold through forced execution proceedings, or (iii) a transfer agreement executed between the transferee and the transferor before a notary public.
Upon submission of the required documentation and payment of the application fees, the review process will commence where the TMMDA shall look into the application to confirm that all regulatory requirements are met, with a particular focus on whether the transferee is well equipped to manage the respective medicinal product in a responsible manner. The TMMDA shall make an assessment on the application within thirty days of the application date, and can request further information or documents, which would re-start the review period. Once the review process is completed, approval will be granted and the MA registry will be updated to reflect the change in the ownership, and the new holder will assume all rights and responsibilities associated with the authorisation.
Share
Related persons
You can contact us for detailed information.


Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
28 March 2025
Circular on the Prevention of Mobbing in Workplaces Has Been Published
On 6 March 2025, Presidential Circular No. 2025/3 on the Prevention of Mobbing at Workplaces (“Circular”) was published in the Official…
26 March 2025
Turkish Cybersecurity Law enters into force
The long-anticipated Cybersecurity Law No. 7545 came into force in Türkiye following its publication in the Official Gazette on 19 March…
24 March 2025
Recent Developments in Healthcare Legislation – Winter Issue 2025
Amendment to the Regulation on the Licensing of Medicinal Products for Human Use. An amendment to the Regulation on the Licensing of…
21 March 2025
Secondary Regulation on Crypto Assets Comes into Force!
Following the provisions introduced to the Capital Markets Law No. 6362 (“CML”) on crypto assets and crypto asset service providers…
11 March 2025
Turkish Data Protection Authority issues new guidelines for the processing of sensitive data
On 26 February 2025, the Turkish Data Protection Authority (“DPA”) published Guidelines on the Processing of Special Categories of Personal…
6 March 2025
Enforcement of Foreign Court Judgments in Türkiye: The Impact of Service Method
The enforcement of foreign court judgments in Türkiye is subject to the conditions set forth in Act No. 5718 on International Private and…